Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • roche

    Tag: roche

    You Searched For "roche"
    Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial

    Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial

    Medical Dialogues Bureau3 Nov 2019 3:30 AM GMT
    Bristol-Myers Squibb said its therapies when administered alongside two courses of chemotherapy demonstrated superior overall survival compared to...
    SETBACK: Novartis Zolgensma study halted by USFDA amid safety concerns

    SETBACK: Novartis Zolgensma study halted by USFDA amid safety concerns

    Medical Dialogues Bureau31 Oct 2019 4:15 AM GMT
    Novartis shares fell 1% at 0715 GMT, while other European drugmakers rose. Analysts said more information was needed to assess whether these findings...
    CDSCO committee tells Roche to submit Phase III clinical trial data of blood cancer combo drug

    CDSCO committee tells Roche to submit Phase III clinical trial data of blood cancer combo drug

    Farhat Nasim27 Oct 2019 6:00 AM GMT
    New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO), recently recommended drugmaker,...
    Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC

    Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC

    Medical Dialogues Bureau22 Oct 2019 4:20 AM GMT
    Roche, in its recent release, in 2018, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for Tecentriq in...
    Roche gets USFDA clearance for cobas pro solutions for diagnostics labs

    Roche gets USFDA clearance for cobas pro solutions for diagnostics labs

    Medical Dialogues Bureau17 Sep 2019 3:45 AM GMT
    With the cobas pro integrated solutions, laboratories are now able to run tests faster on less equipment, automate manual tasks and deliver results...
    Roche touts drugs pipeline, rules out Merger and Acquisition just to boost sales

    Roche touts drugs pipeline, rules out Merger and Acquisition just to boost sales

    Medical Dialogues Bureau7 Sep 2019 3:45 AM GMT
    Roche has twice upgraded 2019 sales forecasts, the latest time to mid- to high-single-digit percentage rate growth, as medicines including Ocrevus for...
    Roche names Eli Lilly executive Levi Garraway as chief medical officer

    Roche names Eli Lilly executive Levi Garraway as chief medical officer

    Medical Dialogues Bureau20 Aug 2019 3:30 AM GMT
    Levi Garraway, most recently Eli Lilly's senior vice president, oncology research and development and Lilly research laboratories novel target...
    Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month

    Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month

    Medical Dialogues Bureau17 Aug 2019 3:45 AM GMT
    Rozlytrek was approved by the U.S. Food and Drug Administration on Thursday to treat certain types of solid tumours, which show rare genetic anomalies...
    Sanofi strikes deal for US rights to Roche Tamiflu

    Sanofi strikes deal for US rights to Roche Tamiflu

    Medical Dialogues Bureau24 July 2019 3:45 AM GMT
    Under the terms of the agreement, Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing,...
    Single dose of Xofluza flu drug as effective as Tamiflu in kids, says Roche

    Single dose of Xofluza flu drug as effective as Tamiflu in kids, says Roche

    Medical Dialogues Bureau6 July 2019 3:45 AM GMT
    Xofluza, an oral treatment, was well tolerated in children, said Roche, whose medicine is already approved broadly in Japan and for people older than...
    Roche wins Japan approval for personalised cancer drug Rozlytrek

    Roche wins Japan approval for personalised cancer drug Rozlytrek

    Medical Dialogues Bureau19 Jun 2019 6:31 AM GMT
    ZURICH: Swiss drugmaker Roche on Tuesday won approval in Japan for Rozlytrek as the world's biggest maker of cancer drugs pushes ahead in personalised...
    Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit

    Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit

    Medical Dialogues Bureau12 Jun 2019 4:00 AM GMT
    Roche's new diagnostics boss, Thomas Schinecker, fills a post that had been led for months on an interim basis by Michael Heuer, who is retiring....
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X